loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 2422948 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 RECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN (1)

filter

01 SANOFI-AVENTIS CANADA INC (1)

filter

01 KIT (1)

filter

01 2000UNIT/VIAL (1)

filter

01 Canada (1)

URL Supplier Web Content
KIT
2000UNIT/VIAL
ALPROLIX
Canada
2422948
Schedule D
Sanofi Company Banner

Cophex 2024

Not Confirmed

envelop Contact Supplier

Looking for CTD TGA MCC DOSSIER APPLICATION 2422948

Looking for CTD TGA MCC DOSSIER APPLICATION 2422948 1

19

Sanofi, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

One of their notable products is RECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN, with a corresponding application number 2422948 and regulatory information .

proudly manufactured in the

Sanofi's ALPROLIX KIT, medication with 2000UNIT/VIAL of RECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN.

Post Enquiry
POST ENQUIRY